Meet the Team

Patients receive state-of-the-art care from a multidisciplinary team of dedicated to treating lung cancer, mesothelioma, esophageal cancer, metastasiic disease to the lungs as well as less common malignancies including sarcomas, and tumors of the thymus, mediastinum, bronchus and chest wall.  In addition, clinical investigators in the program conduct clinical trials for the most promising new therapies.